Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial

Acta Odontologica Scandinavica

Volumn 74, Issue 5, 2016, Pages 399-404

  Jørgensen, Mette Rose ^a   Keller, Mette Kirstine ^a   Kragelund, Camilla ^a   Hamberg, Kristina ^b   Ericson, Dan ^b   Nielsen, Claus Henrik ^a,c   Twetman, Svante ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MALMÖ UNIVERSITY   (Sweden)

^c University of Copenhagen   (Denmark)

Author keywords

Clinical studies; immunoglobulins; interleukins; probiotics

Indexed keywords

IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN DERIVATIVE; PLACEBO; PROBIOTIC AGENT; SALIVA PROTEIN; SECRETORY IMMUNOGLOBULIN;

ADOLESCENT; ADULT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; LACTOBACILLUS REUTERI; MALE; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; SALIVA; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; LACTOBACILLUS REUTERI; MALE; PLACEBOS; PROBIOTICS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; YOUNG ADULT;

EID: 84964412254     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.3109/00016357.2016.1169439     Document Type: Article

References (42)

1. FAO/WHO. Guidelines for the evaluation of probiotics in food. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. [Internet]. London Ontario, Canada: World Health Organization; 2002. Available from: http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
2. L.Y.Wan, Z.J.Chen, N.P.Shah,. Modulation of intestinal epithelial defense responses by probiotic bacteria. Crit Rev Food Sci Nutr. 2015. [Epub ahead of print]. doi:10.1080/10408398.2014.905450.
3. B.Corthesy, H.R.Gaskins, A.Mercenier Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007;137:781s–790s.
4. D.Kelly, S.Conway Bacterial modulation of mucosal innate immunity. Mol Immunol. 2005;42:895–901.
5. K.Shimizu, H.Sato, Y.Suga,. The effects of Lactobacillus pentosus strain b240 and appropriate physical training on salivary secretory IgA levels in elderly adults with low physical fitness: a randomized, double-blind, placebo-controlled trial. J Clin Biochem Nutr. 2014;54:61–66.
6. J.Kabeerdoss, R.S.Devi, R.R.Mary,. Effect of yoghurt containing Bifidobacterium lactis Bb12(R) on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutr J. 2011;10:138.
7. A.M.Bakker-Zierikzee, E.A.Tol, H.Kroes,. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol. 2006;17:134–140.
8. L.Wang, J.Zhang, Z.Guo,. Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition. 2014;30:776–783.e1.
9. B.J.Underdown, J.M.Schiff Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol. 1986;4:389–417.
10. I.D.Miletic, S.S.Schiffman, V.D.Miletic,. Salivary IgA secretion rate in young and elderly persons. Physiol Behav. 1996;60:243–248.
11. P.N.Nair, H.E.Schroeder Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology. 1986;57:171–180.
12. K.M.Jaedicke, P.M.Preshaw, J.J.Taylor Salivary cytokines as biomarkers of periodontal diseases. Periodontology 2000. 2016;70:164–183.
13. M.G.Netea, F.L.van de Veerdonk, J.W.van der Meer,. Inflammasome-independent regulation of IL-1-family cytokines. Annu Rev Immunol. 2015;33:49–77.
14. B.S.Qazi, K.Tang, A.Qazi Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflam. 2011;2011:908468.
15. K.W.Moore, R.de Waal Malefyt, R.L.Coffman,. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.
16. O.Wattanarat, A.Makeudom, T.Sastraruji,. Enhancement of salivary human neutrophil peptide 1-3 levels by probiotic supplementation. BMC Oral Health. 2015;15:19.
17. H.Hallstrom, S.Lindgren, T.Yucel-Lindberg,. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis. Acta Odontol Scand. 2013;71:828–833.
18. S.Twetman, B.Derawi, M.Keller,. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand. 2009;67:19–24.
19. H.Hallstrom, S.Lindgren, C.Widen,. Probiotic supplements and debridement of peri-implant mucositis: a randomized controlled trial. Acta Odontol Scand. 2016;74:60–66.
20. Y.Kotani, S.Shinkai, H.Okamatsu,. Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun Ageing. 2010;7:11.
21. I.S.Surono, F.P.Koestomo, N.Novitasari,. Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: a pilot study. Anaerobe. 2011;17:496–500.
22. D.Paineau, D.Carcano, G.Leyer,. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008;53:107–113.
23. M.Gleeson, N.C.Bishop, M.Oliveira,. Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes. Int J Sport Nutr Exerc Metab. 2012;22:235–242.
24. W.Teughels, A.Durukan, O.Ozcelik,. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40:1025–1035.
25. K.Hatakka, A.J.Ahola, H.Yli-Knuuttila,. Probiotics reduce the prevalence of oral candida in the elderly-a randomized controlled trial. J Dent Res. 2007;86:125–130.
26. E.Kraft-Bodi, M.R.Jorgensen, M.K.Keller,. Effect of probiotic bacteria on oral candida in frail elderly. J Dent Res. 2015;94:181S–186S.
27. L.Nase, K.Hatakka, E.Savilahti,. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35:412–420.
28. R.A.Kekkonen, N.Lummela, H.Karjalainen,. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol. 2008;14:2029–2036.
29. D.Ericson, K.Hamberg, G.Bratthall,. Salivary IgA response to probiotic bacteria and mutans streptococci after the use of chewing gum containing Lactobacillus reuteri. Pathog Dis. 2013;68:82–87.
30. M.Sonesson, K.Hamberg, M.L.Wallengren,. Salivary IgA in minor-gland saliva of children, adolescents, and young adults. Eur J Oral Sci. 2011;119:15–20.
31. E.Tiollier, M.Chennaoui, D.Gomez-Merino,. Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med. 2007;172:1006–1011.
32. H.Dong, I.Rowland, L.V.Thomas,. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Nutr. 2013;52:1853–1863.
33. G.Rizzardini, D.Eskesen, P.C.Calder,. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2012;107:876–884.
34. T.Asama, T.H.Arima, T.Gomi,. Lactobacillus kunkeei YB38 from honeybee products enhances IgA production in healthy adults. J Appl Microbiol. 2015;119:818–826.
35. A.C.Phillips, D.Carroll, P.Evans,. Stressful life events are associated with low secretion rates of immunoglobulin A in saliva in the middle aged and elderly. Brain Behav Immun. 2006;20:191–197.
36. C.G.Engeland, F.N.Hugo, J.B.Hilgert,. Psychological distress and salivary secretory immunity. Brain Behav Immun. 2016;52:11–17.
37. M.R.Giuca, M.Pasini, S.Tecco,. Levels of salivary immunoglobulins and periodontal evaluation in smoking patients. BMC Immunol. 2014;15:5.
38. A.K.Szkaradkiewicz, J.Stopa, T.M.Karpinski Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz). 2014;62:495–500.
39. G.Ince, H.Gursoy, S.D.Ipci,. Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J Periodontol. 2015;86:746–754.
40. J.K.Lee, S.J.Kim, S.H.Ko,. Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis. Oral Dis. 2015;21:705–712.
41. A.J.Flichy-Fernandez, J.Ata-Ali, T.Alegre-Domingo,. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial. J Periodontal Res. 2015;50:775–785.
42. M.R.Jørgensen, M.K.Keller Use of probiotics in future prevention and treatment of oral infections. In: L.A.M.Pedersen, editor. Oral infections and general health: from molecule to chairside. Switzerland: Springer International Publishing; 2016. p. 125–136.